Chen, Aiqi. “CD19 And CD22 Dual-Target CAR-T Therapy Via CRISPR Cas9 Engineering for Relapsed B-Cell Acute Lymphoblastic Leukemia”. Academic Journal of Science and Technology, vol. 18, no. 1, Dec. 2025, pp. 621-5, https://doi.org/10.54097/79zwp242.